Cipla informs about press release

12 Dec 2019 Evaluate

Cipla has informed that it has enclosed press release dated 11th December, 2019 by Avenue Therapeutics Inc., USA, associate company of Cipla, titled 'Avenue Therapeutics Announces Submission of New Drug Application for IV Tramadol'.

The above information is a part of company’s filings submitted to BSE.

Cipla Share Price

1520.55 -0.65 (-0.04%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×